Prevention and treatment of gout

被引：53
|
作者：
Stamp, Lisa K. [1 ]
Dalbeth, Nicola [2 ]
机构：
[1] Univ Otago, Dept Med, Christchurch, New Zealand
[2] Univ Auckland, Dept Med, Auckland, New Zealand
来源：
NATURE REVIEWS RHEUMATOLOGY | 2019年 / 15卷 / 02期
关键词：
DOUBLE-BLIND; CANAKINUMAB; ARTHRITIS;
D O I：
10.1038/s41584-018-0149-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In 2018, advances in the treatment of gout flares came in the form of a new nurse-led management approach to serum urate lowering and evidence that allopurinol might have a better cardiovascular safety profile than febuxostat. However, are IL-1 beta blockers such as canakinumab the future of care for patients with gout?
引用
收藏
页码：68 / 70
页数：4
相关论文
共 50 条
12345